Format

Send to

Choose Destination
Vaccine. 2007 Dec 21;26(1):59-66. Epub 2007 Nov 12.

Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.

Author information

1
Centre for Infections, Health Protection Agency, London NW9 5EQ, UK. Bernard.cohen@hpa.org.uk

Abstract

BACKGROUND:

Clinical trials of measles vaccination administered as aerosol are planned with the aim of obtaining licensure. Measles antibody levels will be measured using the plaque reduction neutralization test (PRNT) to assess antibody responses as a surrogate marker of efficacy.

METHODS:

A working group examined laboratory protocols for measles PRNT in use at three reference centres and agreed to a standardised procedure, which was subsequently validated.

RESULTS:

Assay validation showed quantitative results varied approximately threefold both within and between assays. The lower limit of detection was approximately 20milliInternational Units/mL.

CONCLUSIONS:

A standardised laboratory protocol for measles PRNT was established and validated for use in clinical trials of aerosolized measles vaccines.

PMID:
18063236
DOI:
10.1016/j.vaccine.2007.10.046
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center